Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05557370 · ClinicalTrials.gov registry record · Phase 4
Immunogenicity of HPV Vaccine in Transplant Recipients.
A Phase 4 study of Chronic Kidney Diseases and Kidney Transplant, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05557370 is a Phase 4 study of Chronic Kidney Diseases and Kidney Transplant that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05557370, a Phase 4 study of Chronic Kidney Diseases and Kidney Transplant, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
Conditions Studied
Interventions
- BIOLOGICAL Human Papilloma Virus vaccine (GARDASIL 9)
Study Locations (1)
Wisconsin
- Froedtert Lutheran Memorial Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2035-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05557370
The ClinicalTrials.gov registry entry for NCT05557370 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Human Papilloma Virus vaccine (GARDASIL 9) is the first listed.
NCT05557370 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05557370 about?
NCT05557370 is a clinical study titled "Immunogenicity of HPV Vaccine in Transplant Recipients.". To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
What is the current status of trial NCT05557370?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2023-06-01. Estimated completion is 2035-12-31.
What conditions does trial NCT05557370 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Kidney Transplant.
What interventions are being tested in trial NCT05557370?
The interventions under investigation include: Human Papilloma Virus vaccine (GARDASIL 9) (BIOLOGICAL).
Who is sponsoring clinical trial NCT05557370?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05557370 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral Iron in Children With Chronic Kidney Disease
RECRUITING · Phase 4
-
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
RECRUITING · Phase 4
-
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
RECRUITING · Phase 4
-
Ferric Citrate in ESRD Pilot Project
ACTIVE NOT RECRUITING · Phase 4
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.